Skip to main content
Erschienen in: Neurological Sciences 10/2018

01.10.2018 | Original Article

The serum level of inflammatory markers in chronic and episodic migraine: a case-control study

verfasst von: Fahimeh Martami, Soodeh Razeghi Jahromi, Mansoureh Togha, Zeinab Ghorbani, Maryam Seifishahpar, Atoosa Saidpour

Erschienen in: Neurological Sciences | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

The exact mechanism of the migraine pathophysiology remained unclear. Although there are some reports showing low-grade inflammation in migraineurs, further studies are needed in this field. Thus, we designed a study to evaluate the serum levels of two main proinflammatory markers in migraine patients. In this case-control research, 43 migraine patients (23 chronic and 20 episodic migraineurs) and 40 age-sex-matched headache-free controls were studied. Demographic, dietary, and anthropometric data, headache characteristics, and serum C-reactive proteins (CRP) and tumor necrosis factor-alpha (TNF-α) assessments were collected. The mean ± SD age of the case and control groups were 36.98 ± 9.91 and 34.84 ± 9.75 years respectively. Compared to control subjects, both episodic and chronic migraineurs had significantly higher median levels of TNF-α (0.24, 0.95, and 1.90 pg/ml, respectively; P value < 0.001). Also, we observed a positive association between the TNF-α levels and the odds of having migraine after considering gender, age, body mass index, and dietary intakes of energy, carbohydrate, protein, fat, and mono and poly unsaturated fatty acids in the multivariable regression models (OR = 2.15; 95% CI 1.31–3.52; P value < 0.001). However, no significant association was demonstrated between migraine and serum CRP (OR = 2.91; 95% CI 0.87–9.78; P value = 0.08). These findings supported that inflammatory state could be related to the pathogenesis of migraine and it can thus be suggested that this effect might be beyond migraine progression. Further detailed studies are needed to investigate the importance of these findings in the pathogenesis of migraine headache.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Arulmozhi D, Veeranjaneyulu A, Bodhankar S (2005) Migraine: current concepts and emerging therapies. Vasc Pharmacol 43(3):176–187CrossRef Arulmozhi D, Veeranjaneyulu A, Bodhankar S (2005) Migraine: current concepts and emerging therapies. Vasc Pharmacol 43(3):176–187CrossRef
2.
Zurück zum Zitat Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner TJ, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210CrossRefPubMed Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner TJ, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210CrossRefPubMed
3.
Zurück zum Zitat Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343–349CrossRefPubMed Lipton RB, Bigal ME, Diamond M, Freitag F, Reed M, Stewart WF et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343–349CrossRefPubMed
5.
Zurück zum Zitat Silberstein S, Olesen J, Bousser M, Diener H, Dodick D, First M et al (2005) International Headache Society. The international classification of headache disorders, (ichd-ii)—revision of criteria for 8.2 medication-overuse headache. Headache 45(10):1424–1425CrossRef Silberstein S, Olesen J, Bousser M, Diener H, Dodick D, First M et al (2005) International Headache Society. The international classification of headache disorders, (ichd-ii)—revision of criteria for 8.2 medication-overuse headache. Headache 45(10):1424–1425CrossRef
6.
Zurück zum Zitat Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB (2013) Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health 16(1):31–38CrossRefPubMed Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB (2013) Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Value Health 16(1):31–38CrossRefPubMed
7.
Zurück zum Zitat Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790CrossRefPubMed Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790CrossRefPubMed
8.
Zurück zum Zitat Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52(10):1456–1470CrossRefPubMed Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52(10):1456–1470CrossRefPubMed
9.
Zurück zum Zitat Jahromi SR, Abolhasani M, Meysamie A, Togha M (2013) The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol 12(1):23–27PubMedPubMedCentral Jahromi SR, Abolhasani M, Meysamie A, Togha M (2013) The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol 12(1):23–27PubMedPubMedCentral
10.
Zurück zum Zitat Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, Razeghi Jahromi S (2018) Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci 39(1):63–70CrossRefPubMed Martami F, Ghorbani Z, Abolhasani M, Togha M, Meysamie A, Sharifi A, Razeghi Jahromi S (2018) Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci 39(1):63–70CrossRefPubMed
11.
Zurück zum Zitat Lance JW (1993) Current concepts of migraine pathogenesis. Neurology 43(6 Suppl 3):S11–S15PubMed Lance JW (1993) Current concepts of migraine pathogenesis. Neurology 43(6 Suppl 3):S11–S15PubMed
12.
Zurück zum Zitat Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64(10 suppl 2):S9–S15CrossRefPubMed Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder. Neurology 64(10 suppl 2):S9–S15CrossRefPubMed
13.
Zurück zum Zitat Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5):304–311CrossRefPubMed Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5):304–311CrossRefPubMed
14.
Zurück zum Zitat Bruno PP, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. European Review for Medical and Pharmacological Sciences 11(4):245–248PubMed Bruno PP, Carpino F, Carpino G, Zicari A (2007) An overview on immune system and migraine. European Review for Medical and Pharmacological Sciences 11(4):245–248PubMed
15.
Zurück zum Zitat Duarte H, Teixeira AL, Rocha NP, Domingues RB (2015) Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine. Neurol Sci 36(2):203–208CrossRefPubMed Duarte H, Teixeira AL, Rocha NP, Domingues RB (2015) Increased interictal serum levels of CXCL8/IL-8 and CCL3/MIP-1α in migraine. Neurol Sci 36(2):203–208CrossRefPubMed
16.
Zurück zum Zitat Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931CrossRefPubMed Perini F, D'andrea G, Galloni E, Pignatelli F, Billo G, Alba S et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931CrossRefPubMed
17.
Zurück zum Zitat Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200–207CrossRefPubMed Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2):200–207CrossRefPubMed
18.
Zurück zum Zitat Boćkowski L, Sobaniec W, Żelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41(1):17–21CrossRefPubMed Boćkowski L, Sobaniec W, Żelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41(1):17–21CrossRefPubMed
19.
Zurück zum Zitat Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, Guzel I, Islamoglu Y, Colpan L, Tasdemir N (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 15(10):1111–1116PubMed Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, Guzel I, Islamoglu Y, Colpan L, Tasdemir N (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 15(10):1111–1116PubMed
20.
Zurück zum Zitat Tanik N, Celikbilek A, Metin A, Gocmen AY, Inan LE (2015) Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 36(10):1823–1827CrossRefPubMed Tanik N, Celikbilek A, Metin A, Gocmen AY, Inan LE (2015) Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 36(10):1823–1827CrossRefPubMed
21.
Zurück zum Zitat Wang F, He Q, Ren Z, Li F, Chen W, Lin X, Zhang H, Tai G (2015) Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine. Neurol Sci 36(4):535–540CrossRefPubMed Wang F, He Q, Ren Z, Li F, Chen W, Lin X, Zhang H, Tai G (2015) Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine. Neurol Sci 36(4):535–540CrossRefPubMed
22.
Zurück zum Zitat Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362PubMed Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362PubMed
23.
Zurück zum Zitat Vanmolkot F, De Hoon J (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27(7):843–846CrossRefPubMed Vanmolkot F, De Hoon J (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27(7):843–846CrossRefPubMed
24.
Zurück zum Zitat Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C et al (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol Scand 13(2):205–211 Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C et al (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol Scand 13(2):205–211
25.
Zurück zum Zitat Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(2):s107–ss10CrossRefPubMed Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(2):s107–ss10CrossRefPubMed
26.
Zurück zum Zitat Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E, Savastano S, Ghiggi MR, Tommaselli AP, Lombardi G (1991) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. Int J Neurosci 61(1–2):53–60CrossRefPubMed Covelli V, Massari F, Fallacara C, Munno I, Pellegrino NM, Jirillo E, Savastano S, Ghiggi MR, Tommaselli AP, Lombardi G (1991) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. Int J Neurosci 61(1–2):53–60CrossRefPubMed
27.
Zurück zum Zitat Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache 41(2):129–137CrossRefPubMed Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache 41(2):129–137CrossRefPubMed
28.
Zurück zum Zitat Welch K, Brandes AW, Salerno L, Brandes JL (2006) C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 46(2):197–199CrossRefPubMed Welch K, Brandes AW, Salerno L, Brandes JL (2006) C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 46(2):197–199CrossRefPubMed
29.
Zurück zum Zitat Gudmundsson LS, Aspelund T, Scher AI, Thorgeirsson G, Johannsson M, Launer LJ, Gudnason V (2009) C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29(12):1301–1310CrossRefPubMedPubMedCentral Gudmundsson LS, Aspelund T, Scher AI, Thorgeirsson G, Johannsson M, Launer LJ, Gudnason V (2009) C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29(12):1301–1310CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1):184–188CrossRefPubMed Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171(1):184–188CrossRefPubMed
31.
Zurück zum Zitat Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain 11(5):427–430CrossRefPubMedPubMedCentral Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain 11(5):427–430CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M et al (2017) Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg 1–10 Jahromi SR, Abolhasani M, Ghorbani Z, Sadre-Jahani S, Alizadeh Z, Talebpour M et al (2017) Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg 1–10
33.
Zurück zum Zitat Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-α and IL-12/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138–144CrossRefPubMed Oliveira AB, Bachi ALL, Ribeiro RT, Mello MT, Tufik S, Peres MFP (2017) Unbalanced plasma TNF-α and IL-12/IL-10 profile in women with migraine is associated with psychological and physiological outcomes. J Neuroimmunol 313:138–144CrossRefPubMed
34.
Zurück zum Zitat Kurth T, Ridker P, Buring J (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28(1):49–56CrossRefPubMed Kurth T, Ridker P, Buring J (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28(1):49–56CrossRefPubMed
35.
Zurück zum Zitat Lippi G, Mattiuzzi C, Cervellin G (2014) C-reactive protein and migraine. Facts or speculations? Clin Chem Lab Med 52(9):1265–1272PubMed Lippi G, Mattiuzzi C, Cervellin G (2014) C-reactive protein and migraine. Facts or speculations? Clin Chem Lab Med 52(9):1265–1272PubMed
36.
Zurück zum Zitat Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A et al (2017) Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia 0333102417720213 Dominguez C, Vieites-Prado A, Perez-Mato M, Sobrino T, Rodriguez-Osorio X, Lopez A et al (2017) Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia 0333102417720213
37.
Zurück zum Zitat Empl M, Sostak P, Riedel M, Schwarz M, Müller N, Förderreuther S, Straube A (2003) Decreased sTNF-RI in migraine patients? Cephalalgia 23(1):55–58CrossRefPubMed Empl M, Sostak P, Riedel M, Schwarz M, Müller N, Förderreuther S, Straube A (2003) Decreased sTNF-RI in migraine patients? Cephalalgia 23(1):55–58CrossRefPubMed
38.
Zurück zum Zitat Guldiken B, Guldiken S, Demir M, Turgut N, Kabayel L, Ozkan H, Ozcelik E, Tugrul A (2008) Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 35(4):448–451CrossRefPubMed Guldiken B, Guldiken S, Demir M, Turgut N, Kabayel L, Ozkan H, Ozcelik E, Tugrul A (2008) Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 35(4):448–451CrossRefPubMed
39.
Zurück zum Zitat Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzmán JC, Morillo CA, Vesga B, Pradilla G, Flórez M, López-Jaramillo P (2007) Endothelial function in patients with migraine during the interictal period. Headache 47(1):45–51CrossRefPubMed Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzmán JC, Morillo CA, Vesga B, Pradilla G, Flórez M, López-Jaramillo P (2007) Endothelial function in patients with migraine during the interictal period. Headache 47(1):45–51CrossRefPubMed
40.
Zurück zum Zitat Yilmaz N, Yilmaz M, Sirin B, Yilmaztekin S, Kutlu G (2017) The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura. J Recept Signal Transduct Res 37(5):447–452CrossRefPubMed Yilmaz N, Yilmaz M, Sirin B, Yilmaztekin S, Kutlu G (2017) The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura. J Recept Signal Transduct Res 37(5):447–452CrossRefPubMed
41.
Zurück zum Zitat Heshmat-Ghahdarijani K, Javanmard SH, Sonbolestan SA, Saadatnia M, Sonbolestan SA (2015) Endothelial function in patients with migraine without aura during the interictal period. Int J Prev Med 6:2CrossRefPubMedPubMedCentral Heshmat-Ghahdarijani K, Javanmard SH, Sonbolestan SA, Saadatnia M, Sonbolestan SA (2015) Endothelial function in patients with migraine without aura during the interictal period. Int J Prev Med 6:2CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Mustafa C, Omer Faruk B, Sinan B, Ömer A, Ahmet Y, Dilcan K (2015) Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia 36(6):518–525 Mustafa C, Omer Faruk B, Sinan B, Ömer A, Ahmet Y, Dilcan K (2015) Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia 36(6):518–525
43.
Zurück zum Zitat Hamed SA, Hamed EA, Eldin AME, Mahmoud NM (2010) Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis 19(2):92–103CrossRefPubMed Hamed SA, Hamed EA, Eldin AME, Mahmoud NM (2010) Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis. J Stroke Cerebrovasc Dis 19(2):92–103CrossRefPubMed
44.
Zurück zum Zitat Lord G, Duckworth J (1977) Immunoglobulin and complement studies in migraine. Headache 17(4):163–168CrossRefPubMed Lord G, Duckworth J (1977) Immunoglobulin and complement studies in migraine. Headache 17(4):163–168CrossRefPubMed
45.
Zurück zum Zitat Martelletti P, Sutherland J, Anastasi E, Mario UD, Giacovazzo M (1989) Evidence for an immune-mediated mechanism in food-induced migraine from a study on activated T-cells, IgG 4 subclass, anti-lgG antibodies and circulating immune complexes. Headache 29(10):664–670CrossRefPubMed Martelletti P, Sutherland J, Anastasi E, Mario UD, Giacovazzo M (1989) Evidence for an immune-mediated mechanism in food-induced migraine from a study on activated T-cells, IgG 4 subclass, anti-lgG antibodies and circulating immune complexes. Headache 29(10):664–670CrossRefPubMed
46.
Zurück zum Zitat Covelli V, Munno I, Pellegrino N, Di AV, Jirillo E, Buscaino G (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurologica 12(4):257–263PubMed Covelli V, Munno I, Pellegrino N, Di AV, Jirillo E, Buscaino G (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurologica 12(4):257–263PubMed
47.
Zurück zum Zitat Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C, di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurologica 13(2):205–211PubMed Covelli V, Munno I, Pellegrino N, Altamura M, Decandia P, Marcuccio C, di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurologica 13(2):205–211PubMed
48.
Zurück zum Zitat Zhang X-C, Kainz V, Burstein R, Levy D (2011) Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. PAIN 152(1):140–149CrossRefPubMed Zhang X-C, Kainz V, Burstein R, Levy D (2011) Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. PAIN 152(1):140–149CrossRefPubMed
49.
Zurück zum Zitat Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H (2016) Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20(5):930–936PubMed Yücel M, Kotan D, Çiftçi GG, Çiftçi I, Cikriklar H (2016) Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20(5):930–936PubMed
Metadaten
Titel
The serum level of inflammatory markers in chronic and episodic migraine: a case-control study
verfasst von
Fahimeh Martami
Soodeh Razeghi Jahromi
Mansoureh Togha
Zeinab Ghorbani
Maryam Seifishahpar
Atoosa Saidpour
Publikationsdatum
01.10.2018
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 10/2018
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3493-0

Weitere Artikel der Ausgabe 10/2018

Neurological Sciences 10/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.